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Laser balloon angioplasty combines conventional coronary angio-
plasty with laser energy to transiently heat vascular tissue. Laser 
balloon angioplasty was performed in 21 patients (aged 56 ± 13 
years), including 10 patients treated urgently after acute failure of 
conventional angioplasty and 11 patients treated with elective 
laser balloon angioplasty. Immediately after conventional angio-
plasty, laser doses (1 to 10 doses of 205 to 380 J each) were 
delivered during inflation of the laser balloon to a pressure of 
4 atm. 
Seven (70%) of 10 patients with acute failure of conventional 
angioplasty were successfully treated with laser balloon angio-
plasty, but 3 (30%) were unsuccessfully treated with the laser 
procedure and required emergency coronary artery bypass sur-
gery. In all three failures, the 3 mm laser balloon angioplasty 
catheter was not the optimal size for the vessel. In the 11 patients 
treated with elective laser balloon angioplasty (reference diameter 
2.94 ± 0.22 mm), the minimal luminal diameter increased from 
0.45 ± 0.25 to 1.85 ± 0.46 mm after conventional angioplasty and 
to 2.44 ± 0.29 mm after laser balloon angioplasty (p < 0.001). 
This corresponded to a decrease in diameter stenosis from 84 ± 
9% before to 35 ± 16% after conventional angioplasty and to 
As percutaneous transluminal coronary angioplasty is ap-
plied to patients with increasingly complex coronary anat-
omy, the number of procedures performed annually is 
expected to exceed 300,000 by this year. Although conven-
tional angioplasty is associated with high success and low 
complication rates, its most important disadvantages con-
tinue to be the need to prevent or treat abrupt closure 
and late restenosis (1). Abrupt vessel closure due to dissec-
tion or thrombus, or both, occurs in 3% to 7% of patients 
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15 ± 10% after laser balloon angioplasty (p < 0.001). There were 
no instances of myocardial infarction, emergency coronary artery 
bypass surgery or death and no acute complications related to 
delivery of laser energy in this group. 
Follow-up coronary angiography was performed 5.5 ± 1.1 
months after laser balloon angioplasty in 18 patients discharged 
from the hospital after a successful procedure. Ten patients (56%) 
had angiographic restenosis, defined as recurrent diameter steno-
sis >50%. Six patients were subsequently treated by directional 
coronary atherectomy, which revealed intimal proliferation indis-
tinguishable from that in patients with restenosis after conven-
tional angioplasty. 
In conclusion, laser balloon angioplasty may be effective in 
sealing severe coronary dissections and reversing abrupt closure 
associated with failed conventional angioplasty. After uncompli-
cated conventional angioplasty, laser balloon angioplasty im-
proves immediate luminal dimensions, but restenosis appears to 
be mediated by intimal hyperplasia, similar to that seen after 
conventional angioplasty. 
(J Am Coil CardioI1991;18:193-202) 
treated with conventional angioplasty and requires emer-
gency bypass surgery in 2% to 3% (1-4). Restenosis within 
6 months occurs in 25% to 70% of patients (5-12) and no drug 
regimen to date has reliably reduced the incidence of re-
stenosis (13). 
Laser balloon angioplasty is a new catheter-based tech-
nology that uses laser energy to heat vascular tissue during 
conventional angioplasty. In animal models, laser balloon 
angioplasty results in a larger immediate and long-term 
luminal dimension compared with conventional angioplasty 
by sealing dissections and reducing elastic recoil (14,15). In 
human studies, preliminary data from a multicenter trial (16) 
suggest that laser balloon angioplasty improves lumen di-
mensions compared with those seen immediately after con-
ventional angioplasty, but may have little or no impact on 
preventing late restenosis (17). The purpose of this study is 
to describe the immediate results, clinical and angiographic 
follow-up findings and coronary histopathology in patients 
treated with emergency or elective laser balloon angioplasty. 
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Methods 
Study patients. Between March 1, 1989 and October 1, 
1990,21 patients (aged 56 ± 13 years) undergoing their initial 
coronary angioplasty procedure were enrolled in a study of 
laser balloon angioplasty according to a protocol approved 
by the Committee on Clinical Investigations at Beth Israel 
Hospital (on November 21, 1988), as 1 of 12 centers inves-
tigating the use of this procedure. Ten patients underwent 
emergency laser balloon angioplasty as a salvage procedure 
after abrupt failure of conventional angioplasty and 11 
patients underwent elective laser balloon angioplasty imme-
diately after successful conventional angioplasty. The study 
group included 17 men and 4 women with anginal symptoms 
(Canadian Cardiovasc.:ular Society class I in 1 patient, class 
II in 4 patients, class III in 5 and class IV in 11), including 9 
patients with postinfarction angina. Seventeen patients had 
single-vessel disease and four had multivessel disease. 
Patient selection for emergency laser balloon angioplasty 
for failed conventional angioplasty. Patients in whom con-
ventional angioplasty failed and who were considered ac-
ceptable candidates for coronary artery bypass surgery were 
eligible for inclusion. Conventional angioplasty failure was 
defined as: 1) abrupt closure (total occlusion with Thrombol-
ysis in Myocardial Infarction trial [TIMI] grade 0 or I flow or 
severe dissection associated with impaired anterograde flow 
[TIMI grade 2 flow] and clinical signs of ischemia [ongoing 
angina associated with ST segment changes]); and 2) failure 
to reestablish effective anterograde flow (TIMI grade 3 flow) 
by prolonged (> 3 min) inflations with a conventional or 
perfusion balloon catheter. 
Patient selection for elective laser balloon angioplasty. All 
patients <76 years of age who were candidates for elective 
conventional angioplasty were considered for elective laser 
balloon angioplasty if they were acceptable candidates for 
coronary artery bypass surgery and if they were clinically 
stable (no angina within 12 h of angioplasty). Angiographic 
inclusion criteria included a single lesion in the target vessel 
with >70% diameter stenosis and < I cm length. Patients 
with recent myocardial infarction (<5 days) before coronary 
angioplasty, total occlusion, bifurcation or ostial lesions or 
stenosis of a saphenous vein bypass graft were excluded. 
From March I, 1989 to November l, 1989, only lesions in a 
3 mm vessel were considered because the 3 mm laser 
angioplasty balloon (LBA-II) was the only size then avail-
able. After November 1, 1989,2.5,3 and 3.5 mm balloons 
(LBA-III) became available for clinical investigation. 
Conventional angioplasty procedure. All patients were 
treated with aspirin (325 mg/day) and dipyridamole (50 mg 
four times a day) ~24 h before undergoing conventional 
angioplasty and this treatment was continued indefinitely 
after hospital discharge. After placement of the arterial 
sheath, heparin (10,000 U) was given intravenously and 
further doses were administered to maintain the activated 
clotting time between 250 and 300 s. Heparin infusion was 
continued for 12 to 24 h after angioplasty in elective cases. In 
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patients treated successfully with emergency laser balloon 
angioplasty for failed conventional angioplasty, heparin in-
fusion was continued until a therapeutic prothrombin time 
(15 to 16 s) was achieved with Coumadin (warfarin), which 
was given orally for 3 months after discharge. 
All patients underwent right and left heart catheterization 
and conventional coronary angioplasty using a 0.014 in. 
(0.036 cm) guide wire (Advanced Cardiovascular Systems) 
advanced through an 8 or 9F guiding catheter (Schneider, 
USA). The lesion was dilated with appropriate size balloons 
using at least three inflations to 4 to lO atm (60 to ISO psi) for 
60 to 120 s per inflation. Additional balloon inflations were 
performed to achieve the best angiographic result and a 
minimal residual stenosis <50% (by visual estimate) if pos-
sible. 
Laser balloon angioplasty catheter and laser delivery sys-
tem. The laser balloon angioplasty system consists of a 
modified coronary angioplasty catheter and a laser source, 
as described previously (18). Briefly, the laser balloon an-
gioplasty catheter (Spears laser balloon, USCI Division, 
C.R. Bard) is similar to a conventional angioplasty catheter 
with a 4.3F shaft and a polyethylene teraphthalate balloon 
measuring 20 mm in length. The original prototype for 
clinical use (LBA-II) was only available with a balloon 
measuring 3 mm in diameter and was used in the first 16 
patients. The most recent design (LBA-III) is available with 
balloons measuring 2.5, 3 and 3.5 mm in diameter and was 
used in the last five patients. The triple-lumen catheter 
contains a central lumen to accommodate the guide wire, a 
second lumen for balloon inflation and a third lumen that 
contains the 100 JLm silica fiber-optic, which terminates in a 
special diffusing tip. The diffusing tip of the LBA-III catheter 
provides more even distribution of laser energy over the 
length and circumference of the balloon compared with the 
LBA-II catheter. To enhance transmission efficiency oflaser 
radiation, the balloon was inflated with a 50% solution of 
metrizamide (Amipaque, Sterling Drug) in deuterium oxide 
(D20, Merck and Co.), rather than water. 
The laser source is a 50 W continuous wave neodymium: 
yttrium-aluminum-garnet (Nd:YAG) laser (Quantronix Sys-
tem 1500), which delivers laser radiation in the near infrared 
spectrum at 1,060 nm. Laser doses of 205 to 380 J each were 
delivered in a stepwise decremental dose format over 20 s 
(25 W for 5 s, 15 W for 5 sand 12 W for 10 s for the 3 mm 
LBA-II catheter); these doses have been shown to achieve 
tissue temperatures of 90° to 110°C in vitro (personal com-
munication, W. Scott Andrus, USC!). 
Laser balloon angioplasty technique. Patients were given 
fentanyl (50 to 100 JLg) and midazolam (1 to 2 mg intrave-
nously) immediately before laser balloon angioplasty for 
sedation and analgesia. The laser balloon catheter was 
positioned at the site of the original lesion and during 
inflation of the laser balloon to 4 atm, the guiding catheter 
was flushed with warmed (37°C) heparinized physiologic 
saline solution with potassium chloride (4 mEq/liter). After 
full balloon inflation was achieved, the same solution was 
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used to flush the central guide wire lumen to prevent binding 
of the guide wire to the balloon catheter during laser expo-
sure. The programmed laser dose was delivered over 20 s, 
followed by continued balloon inflation for an additional 30 
to 40 s, allowing the temperature of the arterial wall to return 
to normal. The balloon was then deflated and the laser 
balloon angioplasty catheter removed. Angiography was 
repeated to assess the final result and additional doses were 
delivered with the same laser catheter if clinically indicated. 
For elective cases, one to three laser doses (total dose 205 to 
960 J) were administered, but in two emergency cases with 
long (> 1 balloon length) dissections, mUltiple overlapping 
laser balloon inflations were performed, requiring 5 (total 
dose 1,600 J) and 10 (total dose 3,200 1) doses, respectively. 
Lesion morphology. Lesions were classified as type A, B 
or C according to definitions of the American College of 
Cardiology/American Heart Association Task Force (19), 
based on lesion length, eccentricity and bend point >45°, as 
well as the presence of thrombus, ulceration and calcifica-
tion. Anterograde flow was graded on a scale of 0 to 3 as 
defined by the TIMI study (20). The extent of arterial 
dissection was graded on a scale of 0 to 4 (0 = none; 1 = 
small intimal flap; 2 = moderate intimal flap and focal linear 
dye stain with normal anterograde flow; 3 = large dissection 
but with anterograde flow [TIMI grade 2 or 3 flow]; and 4 = 
abrupt closure without anterograde flow [TIMI grade 0 or 1 
flow]). 
FoUow-up. Clinical follow-up was performed by tele-
phone contact or clinic visit at 1-, 3- and 6-month intervals 
after hospital discharge. Graded exercise tests were per-
formed at 3 and 6 months after laser balloon angioplasty. 
Coronary angiography was recommended for all patients at 6 
months, but was performed earlier if clinically indicated for 
recurrent symptoms. 
Quantitative assessment of angiographic results. Quantita-
tive assessment of minimal lumen diameter and percent 
diameter stenosis was performed before and immediately 
after conventional angioplasty, immediately after laser bal-
loon angioplasty and at the time of follow-up angiography, 
using the angiographic catheter as a reference diameter. 
Dimensions of magnified images were measured with elec-
tronic calipers (Digital Calipers System, Sandhill) as de-
scribed previously (21,22). Views were matched for magni-
fication, angle, skew and table height to obtain the optimal 
view of the lesion. 
Histology. Six patients (five who underwent laser balloon 
angioplasty at Beth Israel Hospital and one who underwent 
the procedure elsewhere) with symptomatic restenosis after 
laser balloon angioplasty were treated by directional coro-
nary atherectomy (Simpson AtheroCath, Devices for Vas-
cular Intervention) at intervals of 76 to 247 days after laser 
balloon angioplasty. Tissue obtained at the time of atherec-
tomy was fixed in formalin. Paraffin sections were stained 
with hematoxylin-eosin, Masson's trichrome and elastic van 
Gieson and analyzed by conventional light microscopy. 
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Table 1. Baseline Angiographic Characteristics of 21 Patients 
Indication for LBA 
Failed PTCA Elective LBA 
(n = 10) (n = 11) 
Lesion location 
LAD 7 6 
LCx I I 
RCA 2 4 
Lesion type' 
A 4 4 
B 6 7 
C 0 0 
Lesion morphology 
Length (mean ± SD) (mm) 5.2 ± 2.5 3.8 ± 1.9 
Eccentric 6 7 
Bend >45°, <90° 2 
Thrombus 2 4 
Ulceration 0 4 
* As defined in reference 19. LAD = left anterior descending artery; 
LBA = laser balloon angioplasty; LCx = left circumflex artery; PTCA = 
conventional coronary angioplasty; RCA = right coronary artery. 
Statistical analysis. Values are reported as mean values ± 
SD. Angiographic variables were analyzed with analysis of 
variance (ANOV A) for repeated measures. Group compari-
sons were performed by using the unpaired Student's t test 
for continuous variables and chi-square analysis for discrete 
variables. 
Results 
Baseline lesion characteristics (Table 1). Lesions were 
located in any vessel and included the left anterior descend-
ing artery in 13 patients, the left circumflex artery in 2 and 
the right coronary artery in 6. Lesions were classified as a 
type A lesion in 8 patients and a type B lesion in 13; patients 
with a type C lesion were excluded. Although all lesions 
were discrete (length <10 mm), lesions were classified as 
type B because of lesion eccentricity in 13 patients, bend 
point between 45° and 90° in 3, angiographic evidence of 
thrombus in 6 and plaque ulceration in 4. 
Emergency laser balloon angioplasty for failed conven-
tional angioplasty. Ten patients underwent emergency laser 
balloon angioplasty because of abrupt failure of conventional 
angioplasty as a result of sudden closure (dissection grade 4 
or TIMI grade 0 flow) in four patients and severe arterial 
dissection (dissection grade 3) with impaired anterograde 
flow (TIMI grade 2 flow) in six (Fig. 1). All four patients with 
abrupt closure had severe angina and ST segment elevation; 
in one ofthe four, it was associated with recurrent thrombus 
formation. All six patients with a severe dissection (grade 3) 
had angina with ST segment changes and delayed antero-
grade flow (TIM! grade 2). 
The length of dissection could be estimated in nine 
patients and was <20 mm in five and >20 mm in four. Failed 
conventional angioplasty in the remaining patient was attrib-
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Figure 1. The impact of emergency laser balloon angioplasty (LBA) 
on flow (TIMI grade) and severity of dissection (dissection grade) in 
10 patients with acute failure of conventional angioplasty (PICA) 
(see text for definitions). A, Laser balloon angioplasty resulted in 
normalization of anterograde flow in 9 of 10 patients. B, Three 
patients had persistent severe dissection (grade 3 or 4) requiring 
emergency coronary artery bypass surgery. Dissection grade could 
not be estimated in one patient with abrupt closure due to thrombus, 
who was managed successfully by laser balloon angioplasty. Each 
line represents one patient, unless otherwise indicated. 
uted to dissection and thrombotic occlusion, but the length 
and grade of dissection could not be reliably measured. 
In all 10 patients, conventional methods failed to reestab-
lish adequate arterial patency, including long (3 to 10 min) 
balloon inflations (n = 10), an oversized balloon (n = 2), a 
perfusion balloon (n = 3) and intravenous dextran (n = 2). In 
an attempt to avoid emergency coronary bypass surgery in 
these 10 patients, emergency laser balloon angioplasty was 
performed. 
The laser balloon was successfully positioned across the 
lesion in all patients. Two to 4 laser doses were delivered in 
eight patients and 5 and 10 doses, respectively, were deliv-
ered to two patients with a long dissection. In one of the 
latter patients, the guide wire became bound to the catheter 
after the seventh dose, requiring replacement of the guide 
wire and laser balloon angioplasty catheter, at which time 
three additional doses were delivered. No other catheter or 
system failure occurred. 
Success of laser balloon angioplasty. This procedure was 
successful in reestabilizing arterial patency in 7 (70%) of the 
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Figure 2. Top panels, Left coronary angiogram in the left anterior 
oblique cranial projection shows subtotal stenosis in the mid left 
anterior descending artery (left panel). Conventional angioplasty 
resulted in abrupt closure due to thrombus (center panel), which was 
treated successfully by laser balloon angioplasty (right panel). 
Middle panels, Follow-up angiography 24 h later shows a widely 
patent lumen (left panel), but the patient developed symptomatic 
restenosis 4 months later (center panel), treated by directional 
coronary atherectomy (right panel). Bottom panel, Tissue removed 
at the time of atherectomy shows atherosclerotic plaque (AP) and 
proliferative intimal hyperplasia (IH) typical of postangioplasty 
restenosis. 
10 patients. Successful laser balloon angioplasty was attrib-
uted to desiccation of thrombus in one patient (desiccated 
thrombus was identified on the balloon after removal) 
(Fig. 2), sealing of dissection in three patients (dissection 
grade 0 or 1 after angioplasty) and stabilization of severe 
dissection in three patients (dissection grade 2 after angio-
plasty) (Fig. 3). Normal anterograde flow (TIMI grade 3) was 
reestablished in all seven patients and resulted in relief of 
anginal symptoms and electrocardiographic evidence of 
acute ischemia. 
The mean luminal diameter after successful laser balloon 
angioplasty was 2.31 ± 0.47 mm, corresponding to a residual 
diameter stenosis of 19 ± 14%. Repeat angiography per-
formed 12 to 24 h after angioplasty demonstrated continued 
arterial patency and normal anterograde flow in all seven 
patients (Fig. 2 and 3), with a mean luminal diameter of 
2.14 ± 0.41 mm and a residual stenosis of 27 ± 10% (p = NS 
versus immediately after angioplasty). All patients were 
discharged from the hospital in stable condition 6.4 ± 2.2 
days after the procedure once the prothrombin time was in 
the therapeutic range. 
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Figure 3. Top panels, Left coronary angiogram in the right anterior 
oblique cranial projection shows subtotal stenosis in the mid left 
anterior descending artery before the first diagonal branch (left 
panel). Conventional angioplasty resulted in abrupt closure due to 
severe (grade 4) dissection (center panel). Emergency laser balloon 
angioplasty resulted in stabilization and partial sealing of dissection 
(residual grade 2 dissection, small arrows) and restoration of normal 
anterograde flow (right panel), avoiding the need for emergency 
surgery. Bottom panels, Follow-up angiography 24 h later shows a 
stable vessel with persistent grade 2 dissection (left panel), but the 
patient developed restenosis 6 months later (center panel), managed 
by successful repeat conventional angioplasty (right panel). Note 
that the restenosis lesion is longer than the original lesion and may 
have been due to intimal proliferation secondary to balloon-induced 
dissection and thermal injury. 
Figure 4. Right coronary angiogram 
in the left anterior oblique projection 
shows an eccentric focal stenosis in 
the mid right coronary artery (4 mm 
vessel) and moderate stenosis in the 
distal right coronary artery before 
the posterior descending artery (left 
panel). Conventional angioplasty of 
the mid right coronary artery lesion 
resulted in TlMI grade 2 flow and 
grade 3 dissection (small arrows) ex-
tending from the original lesion to 
the posterior descending artery (cen-
ter panel). Emergency laser balloon 
angioplasty with a 3 mm catheter 
resulted in restoration of normal an-
terograde flow and relief of acute 
ischemia (right panel), but because 
of persistent severe dissection (large 
arrows) and prominent dye stain in 
the distal vessel (open arrowheads), 
a bailout perfusion catheter was in-
serted and the patient was referred 
for emergency coronary bypass sur-
gery. 
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Failure of laser baBoon angioplasty. This procedure was 
unsuccessful in three patients (30%), all of whom had 
persistent severe dissection (grade 3 dissection in two pa-
tients) or abrupt closure (grade 4 dissection in one patient) 
after laser balloon angioplasty despite the reestablishment of 
normal anterograde flow (TIMI grade 3 flow) in all three 
patients (TIMI grade 0 flow). Because of the unsatisfactory 
appearance of the dissections, all three patients were re-
ferred for emergency coronary artery bypass graft surgery 
after placement of an autoperfusion ("bailout") catheter 
despite the absence of ischemic symptoms or ST segment 
changes in two patients (Fig. 4). 
Failure of laser balloon angioplasty was attributed to the 
lack of availability of appropriate size laser balloon angio-
plasty catheters or the presence of a long spiral dissection, or 
both. These failures included unsuccessful sealing of a 
60 mm long dissection using a 3 mm laser balloon catheter in 
a 4 mm vessel in one patient (Fig. 4); unsuccessful sealing of 
a focal dissection with a 3 mm laser balloon catheter in a 
2.5 mm vessel in one patient (angioplasty resulted in im-
provement in anterograde flow from TIMI grade 2 to 3 and 
resolution of symptoms and ST segment changes, but there 
was persistent grade 3 dissection in both of these patients); 
and successful sealing of part of a 60 mm long dissection 
using a 3 mm laser catheter in the mid-portion of a 3 mm 
vessel in one patient, which was not applied to the distal 
dissection, where the vessel measured only 2 to 2.5 mm in 
diameter. 
Comparison of acute laser balloon angioplasty with conven-
tional angioplasty. To place laser balloon angioplasty in 
perspective, all cases of abrupt failure of conventional 
angioplasty at Beth Israel Hospital in 1989 were reviewed. 
Among 689 conventional angioplasty procedures, 18 patients 
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(2.6%) had persistent angioplasty failure despite conven-
tional methods to reestablish effective anterograde flow. Of 
these 18 patients, 3 had abrupt closure of small sidebranches 
and were treated medically, 9 underwent attempted laser 
balloon angioplasty (the procedure was successful in 6 and 
unsuccessful in 3) and 6 underwent emergency coronary 
bypass surgery without attempted laser balloon angioplasty. 
Therefore, only 9 (1.3%) (3 with unsuccessful laser balloon 
angioplasty, 6 in whom laser balloon angioplasty was not 
attempted) of 689 patients required emergency surgery for 
failed conventional angioplasty. Laser balloon angioplasty 
was not attempted in six patients because of failure to 
successfully recross the occlusion in one patient and lack of 
an appropriately sized laser balloon catheter in five patients 
(a 3.5 mm vessel in three patients and a 2.5 mm vessel in two 
patients before the availability of the LBA-III catheter). 
Currently, all five of these patients, as well as the three in 
whom laser balloon angioplasty was attempted but failed 
(because of the lack of an appropriately sized catheter) 
would be better candidates for emergency laser balloon 
angioplasty. 
Pre·PTCA 
Post·PTCA 
Post·LBA 
Elective laser balloon angioplasty immediately after con· 
ventional angioplasty. In the 11 patients treated with elective 
laser balloon angioplasty, one to four laser doses were 
successfully delivered without catheter or system failures. 
The immediate angiographic results in three patients have 
been reported previously (16). Minimal luminal diameter 
increased from 0.45 ± 0.25 to 1.85 ± 0.46 mm after conven-
tional angioplasty and to 2.44 ± 0.29 mm after laser balloon 
angioplasty. This decrease corresponded to a decrease in 
diameter stenosis from 84 ± 9% to 35 ± 16% after conven-
tional angioplasty and to 15 ± 10% after laser balloon 
angioplasty (p < 0.001). Minimal luminal diameter after 
conventional angioplasty increased after laser balloon angio-
plasty in 10 of the 11 patients (Fig. 5). The only lesion that 
did not improve after laser balloon angioplasty was the 
lesion with the best result after conventional angioplasty 
(minimal luminal diameter 2.6 mm, 11% residual stenosis). A 
3 mm laser balloon catheter was used after a conventional 
3 mm balloon in 10 of the 11 patients; a 3.5 mm balloon was 
used in the remaining patient. 
Conventional coronary angioplasty resulted in a residual 
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Figure 6. Patient 10 in Figure 5. Left coronary angiogram in the 
lateral cranial projection shows an eccentric ulcerated lesion (type 
B) in the mid left anterior descending artery after the first diagonal 
branch (top pane!), with a minimal luminal diameter of 0.67 mm and 
a reference diameter of 3.1 mm. After conventional angioplasty 
(middle pane!), the minimal luminal diameter was only 1.47 mm, 
corresponding to a residual stenosis of 53%. After laser balloon 
angioplasty (bottom pane!), the contour of the lumen improved and 
the minimal luminal diameter increased to 2.3 mm (residual stenosis 
25%). 
stenosis >50% in 3 patients with a type B lesion character-
ized by prominent ulceration (Patients 1,5 and 10) (Fig. 5). 
Laser balloon angioplasty resulted in marked improvement 
in luminal dimensions and contour (Fig. 6) by sealing flaps 
and by smoothing the lumen in all three patients. In addition, 
the laser procedure resulted in angiographic evidence of 
decreased thrombus formation in three of four patients. 
In all five patients with moderate dissection (grade 2) 
after conventional angioplasty, laser balloon angioplasty 
decreased the extent of dissection (grade 0 or 1). All patients 
had normal anterograde flow (TIM I grade 3) after the angio-
plasty procedures. All patients were discharged from the 
hospital in stable condition. 
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Complications. There were no deaths after laser balloon 
angioplasty. Acute myocardial infarction (peak creatine ki-
nase ~2 times the upper limit of normal) occurred in all three 
patients who required emergency bypass surgery (Q wave 
infarction in one, non-Q wave infarction in two) after unsuc-
cessful emergency laser balloon angioplasty for abrupt fail-
ure of conventional angioplasty. One patient developed 
non-Q wave infarction after successful emergency laser 
balloon angioplasty, but this patient already had evidence of 
evolving infarction at the time the emergency procedure was 
initiated (abrupt closure occurred after sheath removal fol-
lowing conventional angioplasty, mandating that the total 
occlusion be recrossed and dilated). 
The average time to laser balloon angioplasty from the 
onset of the last conventional balloon inflation was 31 ± 
14 min (most of which was spent in transporting the laser to 
the appropriate room and warming up the laser). It is 
conceivable that this delay may have contributed to the 
extent of myocardial injury in patients with myocardial 
infarction, but it is likely that the contribution was small. In 
fact, myocardial infarction would have occurred in all 10 
patients if laser balloon angioplasty had not been available. 
Two patients required surgical repair of a femoral artery 
pseudoaneurysm (including one patient who also required a 
blood transfusion), which may have been related to the 
anticoagulation regimen prescribed after successful emer-
gency laser balloon angioplasty. 
Among the patients treated with elective laser balloon 
angioplasty, one patient with angiographic evidence of 
thrombus before conventional angioplasty subsequently de-
veloped progressive thrombus formation that lessened 
slightly after administration of intravenous dextran and 
intracoronary urokinase. This patient had successful laser 
balloon angioplasty (825 J) that was complicated by delayed 
thrombotic occlusion of the vessel (36 h later) and a small 
non-Q wave myocardial infarction (peak creatine kinase MB 
isoenzyme 17 U; normal <10 U). The occlusion was redi-
lated by conventional angioplasty, which was followed by 
recurrent thrombus formation; subsequent repeat laser bal-
loon angioplasty at a higher energy dose (960 J) resulted in 
successful recanalization. One patient developed a superfi-
cial groin infection at the site of sheath insertion, requiring 
antibiotics and local drainage. 
During laser exposure, most patients experienced mild 
pain that generally lasted about 10 s and was distinct from 
their typical angina. Painful sensations did not require pre-
mature termination of laser delivery of radiation in any 
patient. After the laser procedure two patients had asymp-
tomatic coronary spasm (distal to the tip of the balloon) that 
was managed successfully with intracoronary nitroglycerin. 
Follow-up. Complete 6-month clinical and angiographic 
follow-up data were available for all 18 patients discharged 
from the hospital after successful laser balloon angioplasty, 
including 9 patients who presented with symptomatic reo 
stenosis between 4 and 6 months after the procedure and S 
asymptomatic patients who underwent mandatory follow-u~ 
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angiography at 6 months. During the follow-up period, lO 
(56%) of 18 patients developed angiographic evidence for 
restenosis (5 of 7 emergency and 5 of 11 elective laser 
balloon angioplasty procedures). The restenosis was man-
aged by directional coronary atherectomy in five patients 
(Fig. 2), conventional angioplasty in four (Fig. 3) and medi-
cal therapy in one patient. The minimal luminal diameter at 
follow-up study in all patients was 1.31 ± 0.89 mm, corre-
sponding to a diameter stenosis of 55 ± 29% (Fig. 5). From 
laser balloon angioplasty to the follow-up angiogram, the 
mean decrease in minimal luminal diameter was 1.07 ± 
0.89 mm. Two patients had total occlusion of the treated 
segment at follow-up. 
Histology. Six patients (five underwent laser balloon an-
gioplasty at our institution and one had the procedure 
elsewhere) with restenosis after laser balloon angioplasty 
underwent coronary atherectomy 6.1 ± 0.8 months after an 
elective (n = 3) or emergency (n = 3) laser procedure. Light 
microscopy revealed atherosclerotic plaque in all patients, 
media in one patient and organized thrombus in three 
patients. Intimal hyperplasia was identified in all six patients 
and was virtually identical to that associated with restenosis 
after conventional angioplasty (Fig. 2). 
Discussion 
Mechanisms of conventional and laser balloon angioplasty. 
Conventional coronary angioplasty improves luminal dimen-
sions by fracturing plaque and stretching the underlying 
vessel wall, which frequently leads to medial dissection and 
formation of intimal flaps (23). These changes are generally 
well tolerated, but in 6% to 7% of patients, dissection and 
associated thrombus may create local flow abnormalities 
that lead to acute vessel closure. In 50% of these patients, 
emergency coronary artery bypass graft surgery is required 
(1-4). Although most patients do not sustain acute closure, 
initial gains in luminal diameter may be limited by early 
elastic recoil and by the later development of intimal hyper-
plasia leading to restenosis. The ultimate goal of laser 
balloon angioplasty is to create a large smooth lumen in the 
hope of achieving better immediate and long-term results 
compared with those achieved with conventional angio-
plasty. Possible mechanisms of luminal improvement by 
laser balloon angioplasty include thermal welding of dissec-
tion flaps (15,24,25), elimination of elastic recoil and vaso-
spasm (14,26), reduction in platelet activation, desiccation of 
thrombus and inhibition of smooth muscle cell proliferation. 
Data from our study confirm that laser balloon angio-
plasty results in thermal welding of dissection flaps and less 
elastic recoil than that associated with conventional angio-
plasty. In patients with immediate failure of conventional 
angioplasty, the critical mechanism for successful laser 
balloon angioplasty was thermal sealing of dissection be-
cause conventional methods of repeat dilation were not 
successful in reestablishing adequate anterograde flow. The 
laser procedure failed to reverse abrupt closure when the 
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size of the laser angioplasty balloon was improperly matched 
to the size of the vessel, suggesting that use of an undersized 
balloon might lead to insufficient pressure at the site of 
dissection and that an oversized balloon might lead to further 
mechanical disruption of tissue planes despite delivery of 
heat to the vessel wall. 
The favorable impact of laser balloon angioplasty on 
elastic recoil is suggested by immediate improvement in 
luminal dimensions compared with that achieved with con-
ventional angioplasty in lO of 11 patients. Despite the use of 
a 3 mm balloon, conventional angioplasty resulted in a 
minimal luminal diameter of only 1.85 ± 0.46 mm (35 ± 16% 
stenosis) compared with 2.44 ± 0.29 mm (15 ± lO% stenosis) 
after laser balloon angioplasty. However, elastic recoil was 
not eliminated by laser balloon angioplasty because the 
minimal luminal diameter was still less than the diameter of 
the laser balloon. 
Further studies are needed to determine the effects of 
laser balloon angioplasty on platelet activation, thrombus 
formation, vasospasm and smooth muscle cell proliferation. 
Anecdotal experience in the present study suggests that 
reversal of abrupt closure in one patient was associated with 
desiccation of thrombus (laser dose of 960 J). However, 
desiccation of thrombus is not certain because elective laser 
balloon angioplasty at a lower energy dose (825 J) in one 
patient with thrombus was complicated by delayed abrupt 
closure due to recurrent thrombus formation. The ideal laser 
dose required for desiccation of thrombus is not known. 
Furthermore, laser balloon angioplasty does not appear to 
completely inhibit smooth muscle cell proliferation because 
restenosis still occurs, apparently as a result of intimal 
hyperplasia identical to that associated with conventional 
angioplasty. 
Laser balloon angioplasty for abrupt closure. Preliminary 
results from a multicenter trial (27) of laser balloon angio-
plasty in patients with acute closure after conventional 
angioplasty have shown a success rate of95%. In the present 
study, the laser procedure was successful in 7 of 10 patients 
with failed conventional angioplasty due to severe dissection 
or abrupt closure, or both. The mechanisms of success 
included desiccation of thrombus in one patient, sealing of 
dissection in two patients and stabilization of dissection in 
four. Patients with failed conventional angioplasty in the 
present study would have required emergency coronary 
bypass surgery because maximal conventional methods 
(long inflations, perfusion balloons, dextran) were not suc-
cessful in reestablishing adequate anterograde flow. The 
failure of laser balloon angioplasty to help three patients 
suggests that size of the laser balloon should be matched to 
the arterial diameter to achieve sufficient tissue pressure for 
thermal welding. 
Preliminary studies (22,28) of intracoronary stents and 
directional coronary atherectomy devices suggest that these 
new techniques may prove useful for preventing or reversing 
abrupt closure. However, laser balloon angioplasty may be 
more easily and effectively applied to long (>20 mm) spiral 
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dissections, particularly in vessels of relatively small caliber 
(vessel diameter -2.5 mm) and cases of abrupt closure due 
to thrombus, in which atherectomy devices and stents may 
be less effective. 
Laser balloon angioplasty after elective conventional angio-
plasty. Preliminary results of a multicenter trial (17) of 
conventional angioplasty versus laser balloon angioplasty in 
143 patients suggest that for single discrete (mostly type A) 
lesions in a 3 mm vessel, conventional angioplasty with a 
3 mm balloon results in a residual lumen of 1.7 mm, whereas 
laser balloon angioplasty results in a further increase in 
luminal diameter to 2.3 mm. In our study, immediate appli-
cation of laser balloon angioplasty after successful conven-
tional angioplasty led to further improvement in minimal 
luminal diameter in 10 of 11 patients; in addition, luminal 
contour was improved by sealing dissection flaps in 6 of 8 
patients. These data suggest that laser balloon angioplasty 
may improve the immediate angiographic result after con-
ventional angioplasty by sealing dissections and reducing 
elastic recoil. However, the problem of elastic recoil has not 
been eliminated because a 3 mm laser angioplasty balloon 
results in a lumen measuring only 2.4 mm in diameter. 
Laser balloon angioplasty may have a more important 
role in patients with a type B lesion, in which conventional 
angioplasty may be associated with a lower success rate (19). 
In fact, conventional angioplasty was unsuccessful (residual 
stenosis >50%) in three of seven patients with a type B 
lesion in this study, but all three patients had excellent 
angiographic results after laser balloon angioplasty. 
Laser baUoon angioplasty and restenosis. The incidence of 
restenosis after conventional angioplasty is highly variable 
and ranges from 20% to 70%, depending on the nature of the 
original lesion (7-12) and the definition of restenosis (29). 
When restenosis was defined as a residual stenosis >50%, 
follow-up angiography revealed a restenosis rate of 56%. 
Preliminary results of a multicenter randomized trial (17) of 
conventional versus laser balloon angioplasty (using laser 
doses reported in this study) suggest a restenosis rate of 
approximately 40% for both groups. The rates of restenosis 
may be >60% in patients treated with high dose laser balloon 
angioplasty (>435 J per dose) and those treated successfully 
by laser balloon angioplasty for failed conventional angio-
plasty (17,27). Higher laser doses may achieve greater weld 
strength, but laser doses associated with very high tissue 
temperatures may lead to cicatrization. In patients with 
immediate failure of conventional angioplasty, the relative 
risk of emergency surgery (with a perioperative mortality 
rate of approximately 6%) must be weighed against the 
likelihood of restenosis and the associated risks of elective 
repeat angioplasty and coronary bypass surgery. 
Coronary histology after laser balloon angioplasty. Re-
sults of coronary atherectomy in six patients indicated that 
restenosis is associated with intimal proliferation indistin-
guishable from that occurring after conventional angio-
plasty. Although laser balloon angioplasty led to improve-
ment in immediate results compared with those of 
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conventional angioplasty, it apparently did not inhibit the 
process of intimal cellular proliferation. 
Safety. Although the number of patients in this study is 
small, the available data suggest that laser balloon angio-
plasty is safe. There were no major complications (Q wave 
myocardial infarction, emergency coronary bypass surgery 
or death) directly attributable to laser balloon angioplasty, 
and a successful procedure resulted in avoidance of emer-
gency surgery in 7 of 10 patients. In patients treated with 
successful emergency laser balloon angioplasty, the inci-
dence of myocardial infarction was 14%, which is identical 
to the incidence of myocardial infarction in patients with 
abrupt closure who undergo successful redilation by conven-
tional methods (4). However, if a time delay is anticipated in 
readying the laser, a perfusion balloon or a reperfusion 
catheter should be used to avoid prolonged ischemia. 
Limitations. There are several limitations of the present 
study. 1) Laser balloon angioplasty was performed with the 
original catheter prototype (LBA-II) in the first 16 patients, 
whereas the current catheter prototype (LBA-III) was used 
only in the last 5 patients. The diffusing tip of the LBA-III 
catheter has improved axial and radial diffusion of laser 
energy, but whether it results in a better clinical outcome is 
not known. 2) The optimal laser dose has not yet been 
determined and different doses may be required for different 
clinical indications (sealing of dissection, desiccation of 
thrombus, elimination of spasm and recoil). 3) Despite the 
apparent immediate improvement in luminal dimensions and 
contour after laser balloon angioplasty, the clinical signifi-
cance of these observations is unknown. It seems reasonable 
that a larger immediate dimension should be associated with 
a larger dimension at follow-up study, but this speculation 
has yet to be substantiated. 4) The number of patients in this 
study is too small to permit conclusions about the incidence 
of restenosis. It is fair to conclude, however, that current 
laser balloon angioplasty technology will not eliminate the 
problem of restenosis, although future refinements in laser 
catheters and doses may be beneficial. 5) The relative merits 
of laser balloon angioplasty compared with conventional 
angioplasty and other new investigational devices must 
await the availability of future randomized trials. 
Conclusions. Laser balloon angioplasty appears to have a 
promising role in the treatment of severe coronary dissec-
tions and reversal of abrupt closure associated with failed 
conventional coronary angioplasty by virtue of sealing dis-
sections and desiccation of thrombus. Elective laser balloon 
angioplasty is more effective at enlarging acute luminal 
dimension than is conventional dilation with the same size 
balloon, particularly in complex lesions, by sealing dissec-
tions and reducing elastic recoil. Despite the acute improve-
ments in luminal dimension and contour, however, laser 
balloon angioplasty does not prevent smooth muscle cell 
proliferation leading to restenosis. The relative merits of 
laser balloon angioplasty with respect to safety, as well as 
immediate and long-term efficacy, can only be established by 
a larger randomized trial. 
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